FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 354:1109-1112 March 16, 2006 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Interview Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

The anticipated licensure within the next three months of a vaccine against human papillomavirus (HPV) would represent a major public health advance against cervical cancer and other, less common cancers, including those of the anus, penis, vagina, and vulva. The Food and Drug Administration (FDA) is conducting a six-month priority review of Merck's investigational HPV vaccine and should announce its licensing decision by June 8. Questions remain, however, about the potential behavioral consequences of routinely vaccinating adolescents against a sexually acquired infection, and the public reaction is uncertain.

Genital HPV infection is common, with an estimated 6.2 million new infections . . . [Full Text of this Article]

Source Information

Dr. Steinbrook is a national correspondent for the Journal.

An interview with Dr. Douglas Lowy, chief of the Laboratory of Cellular Oncology at the National Cancer Institute, can be heard at www.nejm.org.

This article has been cited by other articles:

• Frieden, T. R., Myers, J. E., Krauskopf, M. S., Farley, T. A. (2008). A Public Health Approach to Winning the War Against Cancer. The Oncologist 13: 1306-1313 [Abstract] [Full Text]  
• Robertson, C, Jayasuriya, A, Allan, P S (2007). Sexually transmitted infections: where are we now?. JRSM 100: 414-417 [Full Text]  
• Wood, C. E., Chen, Z., Cline, J. M., Miller, B. E., Burk, R. D. (2007). Characterization and Experimental Transmission of an Oncogenic Papillomavirus in Female Macaques. J. Virol. 81: 6339-6345 [Abstract] [Full Text]  
• Zacharisen, M. C., Conley, S. F. (2006). Recurrent Respiratory Papillomatosis in Children: Masquerader of Common Respiratory Diseases. Pediatrics 118: 1925-1931 [Abstract] [Full Text]  
• Ibrahim, M. A. (2006). Editorial: Vaccines and Public Health. Epidemiol Rev 28: 1-2 [Full Text]  
• Dasbach, E. J., Elbasha, E. H., Insinga, R. P. (2006). Mathematical Models for Predicting the Epidemiologic and Economic Impact of Vaccination against Human Papillomavirus Infection and Disease. Epidemiol Rev 28: 88-100 [Abstract] [Full Text]  
• (2006). Gardasil: A Quadrivalent Human Papillomavirus Vaccine. JWatch Infect. Diseases 2006: 12-12 [Full Text]  
• Lo, B. (2006). HPV vaccine and adolescents' sexual activity.. BMJ 332: 1106-1107 [Full Text]